Some Baidyanath products contain lead:NYC health department

Image
Press Trust of India New York
Last Updated : Jul 25 2015 | 3:22 PM IST
The New York City Health Department has asked city residents to stop using certain Ayurvedic medications made by a leading Indian pharma company, saying the products contain "elevated" levels of lead and mercury making them unsafe for "human consumption".
It also recommended that New Yorkers "should immediately stop using these products" and those who have been consuming them should consult with their doctor and consider receiving tests for exposure to lead or other heavy metals.
The department has also asked residents to report to authorities about stores selling the products.
"The New York City Health Department advises New Yorkers to avoid certain Ayurvedic medications made in India by Shree Baidyanath as they have been found to contain elevated levels of arsenic, lead and mercury," it said in a statement issued yesterday.
The department issued Commissioner's Orders to cease sales at neighborhood stores where the products were found.
"Although not all Ayurvedic medications contain dangerous ingredients, lead and other heavy metals may be intentionally added to some of these medications for perceived therapeutic benefits. Ayurvedic medications are generally not tested for safety," Bureau of Environmental Disease and Injury Prevention Assistant Commissioner Nancy Clark said.
"These products are not safe for human consumption. No one should sell these products and no one should use them."
In many of the products, the heavy metal content "greatly exceeded the acceptable limits".
The levels of heavy metals found in these medications manufactured exceed the limits for arsenic (3 ppm), lead (2 ppm), and/or mercury (1 ppm) for certain food additives as referenced by the Food and Nutrition Board, Institute of Medicine of the National Academies, the department said.
Products had levels as high as 27,000 ppm of mercury, 470 ppm of lead and 240 ppm of arsenic, it added.
When contacted by PTI, an official at Baidyanath's New Delhi office said the company will look into the matter to determine whether the products in question are that of Baidyanath's or are being sold by another company.
He added that Baidyanath had not yet been approached by the NYC health department regarding its products and even maintained that Baidyanath does not export to the US.
The NYC department warned that people who regularly use products containing high levels of heavy metals are at an increased risk for harmful health effects, including damage to the brain, kidneys, nervous and reproductive systems.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 25 2015 | 3:22 PM IST

Next Story